Personalis, Inc. (NASDAQ:PSNL) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET

Company Participants

Caroline Corner - IR
Chris Hall - CEO and President
Aaron Tachibana - CFO and COO
Rich Chen - CMO and EVP, R&D

Conference Call Participants

Madison Pasterchick - Morgan Stanley
Vidyun Bais - BTIG
Thomas Flaten - Lake Street
Arthur He - H.C. Wainwright

Operator

Good day and welcome to the Personalis Second Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded.

I would now like to turn the conference over to Mr. Caroline Corner, Investor Relations. Please go ahead.

Caroline Corner

Thank you, operator. Welcome to Personalis’ second quarter 2024 earnings call. Joining today’s call are Chris Hall, Chief Executive Officer and President; Aaron Tachibana, Chief Financial and Chief Operating Officer; and Rich Chen, Chief Medical Officer and EVP, R&D.

All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements within the meaning of U.S. securities laws. For example, any statements regarding trends and expectations for our financial performance this year and longer term, cash runway, revenue expectations and timing, reimbursement goals, size and booking of orders, products, services, technology, clinical milestones, the outcome and timing of reimbursement decisions, expectations for our existing and future collaboration activities, cost expectations, our market opportunity, and business outlook.

These statements are subject to risks and uncertainties that could cause actual results to differ materially from our current expectations. We encourage you to review our most recent filings with the SEC, including the risk factors described in our most recent filings. Personalis undertakes no obligation to update these statements, except as required by applicable law.

Our press release with our second quarter 2024 results is available on our website www.personalis.com under the Investors section and includes additional details about our financial results. Our website also has our latest SEC filings, which we encourage you to review. A recording of today’s call will be available on our website by 5 P.M. Pacific Time today.

Now, I would like to turn the call over to Chris for his comments and second quarter business highlights.

Chris Hall

Thank you, Caroline. Good afternoon everyone and thank you for joining us. I'm very proud of our team at Personalis as we continue to fight cancer and help patients with our novel technologies.